146 related articles for article (PubMed ID: 37790602)
1. Smaller and Denser Speech Graphs in Nondemented Patients with Progressive Supranuclear Palsy.
Ma J; Zhang G; Sun X; Chan P; Ye Z
Behav Neurol; 2023; 2023():3771601. PubMed ID: 37790602
[TBL] [Abstract][Full Text] [Related]
2. Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy.
Ma J; Zhang G; Zhao Z; Chan P; Ye Z
Brain Behav; 2024 Jul; 14(7):e3606. PubMed ID: 38945805
[TBL] [Abstract][Full Text] [Related]
3. Graph Theoretical Analysis of Semantic Fluency in Patients with Parkinson's Disease.
Zhang G; Ma J; Chan P; Ye Z
Behav Neurol; 2022; 2022():6935263. PubMed ID: 35502419
[TBL] [Abstract][Full Text] [Related]
4. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
[TBL] [Abstract][Full Text] [Related]
5. Acoustical analysis of speech in progressive supranuclear palsy.
Skodda S; Visser W; Schlegel U
J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
[TBL] [Abstract][Full Text] [Related]
7. Track density imaging in progressive supranuclear palsy: A pilot study.
Nigro S; Bianco MG; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Augimeri A; Quattrone A
Hum Brain Mapp; 2019 Apr; 40(6):1729-1737. PubMed ID: 30474903
[TBL] [Abstract][Full Text] [Related]
8. Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis.
Del Prete E; Tommasini L; Mazzucchi S; Frosini D; Palermo G; Morganti R; Pagni C; Tognoni G; Bonuccelli U; Ceravolo R
Neurol Sci; 2021 Apr; 42(4):1483-1490. PubMed ID: 32851538
[TBL] [Abstract][Full Text] [Related]
9. Impaired sequence manipulation in non-demented patients with progressive supranuclear palsy.
Zhang G; Ma J; Chan P; Ye Z
Brain Behav; 2024 May; 14(5):e3527. PubMed ID: 38702898
[TBL] [Abstract][Full Text] [Related]
10. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
Talai AS; Sedlacik J; Boelmans K; Forkert ND
Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
13. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
[TBL] [Abstract][Full Text] [Related]
14. Utilizing speech analysis to differentiate progressive supranuclear palsy from Parkinson's disease.
Kang K; Nunes AS; Sharma M; Hall AJ; Mishra RK; Casado J; Cole R; Derhammer M; Barchard G; Najafi B; Vaziri A; Wills AM; Pantelyat A
Parkinsonism Relat Disord; 2023 Oct; 115():105835. PubMed ID: 37678101
[TBL] [Abstract][Full Text] [Related]
15. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
[TBL] [Abstract][Full Text] [Related]
16. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
[TBL] [Abstract][Full Text] [Related]
17. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
[TBL] [Abstract][Full Text] [Related]
18. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
[TBL] [Abstract][Full Text] [Related]
19. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
Tommasini L; Bonaccorsi J; Del Prete E; Cintoli S; Pagni C; Mazzucchi S; Palermo G; Morganti R; Frosini D; Siciliano G; Tognoni G; Ceravolo R
Clin Neuropsychol; 2023 Aug; 37(6):1207-1220. PubMed ID: 35997036
[No Abstract] [Full Text] [Related]
20. Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy.
Wittstock M; Pohley I; Walter U; Grossmann A; Benecke R; Wolters A
J Neural Transm (Vienna); 2013 Mar; 120(3):453-61. PubMed ID: 22892823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
